Novartis Novice Eulerpool

Novartis Novice o delnici

Novartis spremljajo številni novinarji in vlagatelji po vsem svetu. Najnovejše Novartis novice zbiramo in objavljamo tukaj.

• 28. november ·

  SeekingAlpha
  Janus Henderson European Focus Fund Q3 2024 Commentary
• 27. november ·

  Yahoo
  EC approves Novartis’ Kisqali to treat early breast cancer
• 27. november ·

  Yahoo
  Novartis Kisqali® receives European Commission approval in a broad population of patients with HR+/HER2- early breast cancer at high risk of recurrence
• 26. november ·

  Yahoo
  FDA Begins Review of Alnylam's sNDA for Expanded Amvuttra Use
• 26. november ·

  Yahoo
  Novartis to present data from mpre than 65 abstracts as ASH, SABCS
• 25. november ·

  Yahoo
  MNOV: Monetary Damages Due Following Sanofi/Novartis Patent Dispute Settlement…
• 25. november ·

  Yahoo
  Novartis highlights new 96-week results from Phase III Scemblix® ASC4FIRST trial at ASH and late-breaking analysis from Phase III Kisqali® NATALEE trial at SABCS
• 23. november ·

  Yahoo
  Are Hedge Funds Banking on Novartis AG (NVS)’s Core Income Growth?
• 22. november ·

  Yahoo
  Pharma Stock Roundup: EU Nod for PFE's Hympavzi, NVS Ups Sales View
• 22. november ·

  Yahoo
  Novartis Raises Sales Outlook for Mid-Term, Acquires Kate Therapeutics